Works by Krammer, Peter H.


Results: 124
    1

    The chains of death.

    Published in:
    Cell Cycle, 2013, v. 12, n. 2, p. 193, doi. 10.4161/cc.23464
    By:
    • Schleich, Kolja;
    • Krammer, Peter H.;
    • Lavrik, Inna N.
    Publication type:
    Article
    2
    3
    4
    5

    Two CD95 (APO-1/Fas) signaling pathways.

    Published in:
    EMBO Journal, 1998, v. 17, n. 6, p. 1675, doi. 10.1093/emboj/17.6.1675
    By:
    • Scaffidi, Carsten;
    • Fulda, Simone;
    • Srinivasan, Anu;
    • Friesen, Claudia;
    • Feng Li;
    • Tomaselli, Kevin J.;
    • Debatin, Klaus-Michael;
    • Krammer, Peter H.;
    • Peter, Marcus E.
    Publication type:
    Article
    6
    7

    Treatment resistance analysis reveals GLUT‐1‐mediated glucose uptake as a major target of synthetic rocaglates in cancer cells.

    Published in:
    Cancer Medicine, 2021, v. 10, n. 19, p. 6807, doi. 10.1002/cam4.4212
    By:
    • Sieber‐Frank, Julia;
    • Stark, Hans‐Jürgen;
    • Kalteis, Simon;
    • Prigge, Elena‐Sophie;
    • Köhler, Richard;
    • Andresen, Carolin;
    • Henkel, Thomas;
    • Casari, Georg;
    • Schubert, Tobias;
    • Fischl, Wolfgang;
    • Li‐Weber, Min;
    • Krammer, Peter H.;
    • von Knebel Doeberitz, Magnus;
    • Kopitz, Jürgen;
    • Kloor, Matthias;
    • Ahadova, Aysel
    Publication type:
    Article
    8

    AIDS and the death receptors.

    Published in:
    British Medical Bulletin, 1997, v. 53, n. 3, p. 604, doi. 10.1093/oxfordjournals.bmb.a011633
    By:
    • Peter, Marcus E;
    • Ehret, Andreas;
    • Berndt, Christina;
    • Krammer, Peter H
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Life and death in peripheral T cells.

    Published in:
    Nature Reviews Immunology, 2007, v. 7, n. 7, p. 532, doi. 10.1038/nri2115
    By:
    • Krammer, Peter H.;
    • Arnold, Rüdiger;
    • Lavrik, Inna N.
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    26
    27
    28

    Differential sensitivity of human papillomavirus type 16.

    Published in:
    International Journal of Cancer, 2001, v. 93, n. 6, p. 823, doi. 10.1002/ijc.1405
    By:
    • Aguilar-Lemarroy, Adriana;
    • Kirchhoff, Sabine;
    • Whitaker, Noel;
    • Gariglio, Patricio;
    • zur Hausen, Harald;
    • Krammer, Peter H.;
    • Rösl, Frank
    Publication type:
    Article
    29
    30
    31

    TAp63 and ΔNp63 in Cancer and Epidermal Development.

    Published in:
    Cell Cycle, 2007, v. 6, n. 3, p. 274, doi. 10.4161/cc.6.3.3797
    By:
    • Candi, Eleonora;
    • Dinsdale, David;
    • Rufini, Alessandro;
    • Salomoni, Paolo;
    • Knight, Richard A.;
    • Mueller, Martina;
    • Krammer, Peter H.;
    • Melino, Gerry
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Tumor counterattack: fact or fiction?

    Published in:
    Cancer Immunology, Immunotherapy, 2005, v. 54, n. 11, p. 1127, doi. 10.1007/s00262-005-0680-7
    By:
    • Igney, Frederik H.;
    • Krammer, Peter H.
    Publication type:
    Article
    41
    42
    43

    Letter to the Editor.

    Published in:
    Cell Death & Differentiation, 1999, v. 6, n. 9, p. 821, doi. 10.1038/sj.cdd.4400569
    By:
    • Schmitz, Ingo;
    • Walczak, Henning;
    • Krammer, Peter H;
    • Peter, Marcus E
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50